Kite Pharma
Santa Monica
California
United States
316 articles about Kite Pharma
-
Kite Pharma Initiates Phase II Clinical Study Of KTE-C19 (ZUMA-2) In Patients With Relapsed Or Refractory Mantle Cell Lymphoma (R/R MCL) To Support Registration For A Second Indication
11/9/2015
-
Kite Pharma To Present Four Abstracts, Including Safety And Efficacy Data From The KTE-C19 Phase I Study In Patients With Refractory, Aggressive NHL (ZUMA-1), At The 57th American Society of Hematology Annual Meeting
11/5/2015
-
Kite Pharma To Present At Upcoming Investor Conferences In November 2015
11/4/2015
-
Onco-Immunology Companies like Juno, Novartis AG, Kite Pharma Struggle to Mass Produce Custom Cancer Therapies
11/2/2015
-
Kite Pharma Initiates ZUMA-1 Phase II In Patients With Aggressive, Refractory Non-Hodgkin's Lymphoma (NHL) To Support Registration Of KTE-C19
11/2/2015
-
SoCal's Kite Pharma Strikes Cancer Deal Worth $535 Million+ with Alpine Immune Sciences
10/28/2015
-
Kite Pharma Announces Exclusive License With The NIH For T Cell Receptor (TCR)-Based Products To Treat Tumors Expressing MAGE
10/20/2015
-
Kite Pharma Receives Positive Opinions For Orphan Drug Designation In The European Union (EU) For KTE-C19 In Three Additional Hematological Indications
10/15/2015
-
Kite Pharma Commends Steven A. Rosenberg, M.D., Ph.D., On The Prestigious Medal Of Honor Award From The American Cancer Society
10/7/2015
-
Kite Pharma Announces Peer-Reviewed Publication Of T Cell Receptor Based Product Candidate To Treat HPV-Associated Cancers
10/1/2015
-
Franz B. Humer, Former Chairman And CEO Of Roche Group, Appointed To Kite Pharma's Board Of Directors
9/15/2015
-
Kite Pharma Expands Collaboration With Netherlands Cancer Institute (NCI)
9/14/2015
-
Kite Pharma Receives Positive Opinion For Orphan Drug Designation In The European Union For KTE-C19, Kite's Lead Cancer T-Cell Immunotherapy
9/11/2015
-
Kite Pharma Commends Honors Conferred To Scientific Advisory Board Members For Their Significant Contributions To Medicine
9/4/2015
-
Kite Pharma To Participate In Upcoming Investor Conferences In September 2015
9/3/2015
-
Why Kite Pharma Needs To Shut Its Big Mouth
8/18/2015
-
Kite Pharma CEO Refutes Rumors of Death Associated with Experimental Cancer Drug
8/18/2015
-
Kite Pharma To Hold Conference Call To Provide A Corporate Update On Monday, August 17, 2015
8/17/2015
-
Kite Pharma Reports Second Quarter 2015 Financial Results
8/11/2015
-
Kite Pharma Breaks Ground on New Facility in SoCal That Will Create 200 New Jobs
8/10/2015